Aiseptron

Curated by Signal

AI-powered paediatric sepsis prediction tool

Overview

AI-powered paediatric sepsis prediction tool. The company focused on developing artificial intelligence-based prediction models to identify the risk of serious infections and sepsis in children in real-time.

Key facts

Founded: 2022
Headquarters: Westminster, United Kingdom
Stage: Sign up to view
Industry: Health Technology

Business model

3 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Bloom Botanics
Provider of an online retailing platform for cannabis-based products
Health TechnologyNewry, United Kingdom
Cloud4Dentists
Provider of cloud-based dental practice management software
Health TechnologyLondon, United Kingdom
Fitter 365
Provider of online fitness workouts and nutrition plans for health management
Health TechnologyRoyal Tunbridge Wells, United Kingdom

About Aiseptron

What does Aiseptron do?

AI-powered paediatric sepsis prediction tool.

Where is Aiseptron headquartered?

Aiseptron is headquartered in Westminster, United Kingdom.

When was Aiseptron founded?

Aiseptron was founded in 2022.

Which sector is Aiseptron in?

Aiseptron operates in Health Technology.

Who are Aiseptron's competitors?

Companies similar to Aiseptron include Bloom Botanics, Cloud4Dentists, and Fitter 365.